Waksal Harlan - Insider Non-Derivative Transactions at Lyra Therapeutics, Inc. (LYRA) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Mar 18, 2024, Waksal Harlan's relationship to Lyra Therapeutics, Inc. (LYRA) is Director,Officer (Executive Chair), and currently has 536,966 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other LYRA insiders.
Data Source: SEC.
Waksal Harlan - Insider Non-Derivative Transactions of LYRA Common Stock
Waksal Harlan - Insider Non-Derivative Transactions at LYRA
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Mar 19, 2024 | Acquisition -- (Common Stock) | 275000 | 0 | 536966 |
| Nov 11, 2023 | P -- (Common Stock) | 25000 | 2.96 | 261966 |